Maxitrol

Neomycin Sulfate, Polymyxin B Sulfate and Dexamethasone, the active ingredients in Maxitrol, are a corticosteroid/antibiotic combination presented as an ophthalmic suspension for ocular use. It treats bacterial and inflammatory eye conditions such as conjunctivitis, allergic reactions and post‑operative inflammation in both adults and children.

GNH USA supplies Maxitrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maxitrol is used to manage ocular infections and inflammation across several common eye conditions.

- Bacterial conjunctivitis: reduces bacterial load and associated inflammation in infected eyes. - Allergic conjunctivitis: alleviates allergic swelling, redness and itching. - Post‑operative eye inflammation: controls inflammation and prevents infection after eye surgery. - Ocular inflammation (non‑infectious): diminishes swelling, pain and redness in various inflammatory eye disorders.

Common Side Effects: - Burning or stinging sensation upon instillation. - Transient blurred vision. - Mild eye irritation or itching. - Temporary foreign‑body feeling. - Slight eyelid edema. - Mild conjunctival redness.

Serious or Rare Side Effects: - Allergic reaction with swelling, rash or hives. - Severe eye pain or worsening redness. - Vision loss or sudden decrease in visual acuity. - Secondary ocular infection or corneal ulceration. - Elevated intra‑ocular pressure leading to glaucoma. - Persistent or worsening inflammation despite therapy.

Before using Maxitrol, consider the following precautions. - Confirm bacterial infection: ensure the condition is bacterial before initiating therapy. - Avoid viral or fungal eye infections: corticosteroids may exacerbate non‑bacterial pathogens. - Monitor intra‑ocular pressure: patients with steroid‑responsive glaucoma need regular pressure checks. - Limit duration: do not exceed the prescribed treatment period without medical review. - Store at room temperature: keep in the original container, protect from light and moisture.

Maxitrol may interact with other ophthalmic agents.

Major Interactions (Avoid): - Systemic corticosteroids: may increase systemic steroid exposure. - Contact lens wear: can enhance drug absorption and cause irritation. - Concurrent ophthalmic antibiotics: may lead to additive toxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: may affect healing response. - Anticholinergic eye drops: could reduce tear production and exacerbate dryness. - Topical ocular anesthetics: may mask early signs of irritation or infection.